Ignite Creation Date:
2025-12-24 @ 9:12 PM
Ignite Modification Date:
2026-04-02 @ 10:13 AM
Study NCT ID:
NCT04466904
Status:
COMPLETED
Last Update Posted:
2021-07-23
First Post:
2020-07-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Multiple-dose Tolerability and Pharmacokinetic of IBI362 in Chinese Patients With T2DM
Sponsor:
Innovent Biologics (Suzhou) Co. Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-12
Start Date Type:
ACTUAL
Primary Completion Date:
2021-05-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-05-28
Completion Date Type:
ACTUAL
First Submit Date:
2020-07-01
First Submit QC Date:
None
Study First Post Date:
2020-07-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-07-21
Last Update Post Date:
2021-07-23
Last Update Post Date Type:
ACTUAL